Triglycerides and HDL cholesterol: stars or second leads in diabetes?
Bitzur
Rafael
R
Bert W. Strassburger Lipid Center, Chaim Sheba Medical Center, Tel Hashomer, Israel. rafael.bitzur@sheba.health.gov.il
Cohen
Hofit
H
Kamari
Yehuda
Y
Shaish
Aviv
A
Harats
Dror
D
D050197:Atherosclerosis / Q000097:blood / Q000453:epidemiology / Q000401:mortality; D002318:Cardiovascular Diseases / Q000097:blood / Q000453:epidemiology / Q000401:mortality; D008076:Cholesterol, HDL / Q000097:blood*; D003327:Coronary Disease / Q000097:blood / Q000453:epidemiology / Q000401:mortality; D048909:Diabetes Complications / Q000097:blood* / Q000188:drug therapy; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000150:complications / Q000188:drug therapy / Q000401:mortality; D003925:Diabetic Angiopathies / Q000097:blood* / Q000188:drug therapy; D050171:Dyslipidemias / Q000097:blood; D015525:Fatty Acids, Omega-3 / Q000627:therapeutic use; D006801:Humans; D009525:Niacin / Q000627:therapeutic use; D047493:PPAR alpha / Q000819:agonists; D020521:Stroke / Q000097:blood / Q000453:epidemiology / Q000401:mortality; D014280:Triglycerides / Q000097:blood*
D008076:Cholesterol, HDL; D015525:Fatty Acids, Omega-3; D047493:PPAR alpha; D014280:Triglycerides; D009525:Niacin